GlaxoSmithKline agreed to pay Novartis $13 billion for its 36.5% stake in their consumer health care joint venture, moving to consolidate the unit just three years after it and Novartis joined forces.
from WSJ.com: US Business https://ift.tt/2pHNjh4
via IFTTT
No comments:
Post a Comment